REGISTER NOW
Interactive Teleconference Series
Current and Emerging Approaches to Attain Remission in Ulcerative Colitis

Jointly sponsored by the University of Cincinnati and Princeton CME
Teleconference Dates

Participating Faculty
Presenters
William J. Sandborn, MD
Professor of Medicine
Mayo Clinic College of Medicine
Vice Chairman
Division of Gastroenterology and Hepatology
Mayo Clinic
Rochester, Minnesota
Q&A Cohost
Randolph V. Fugit, PharmD, BCPS
Internal Medicine Clinical Specialist
Denver Veterans Affairs Medical Center
Adjoint Assistant Professor, Pharmacy Practice
University of Colorado Health Sciences Center
Denver, Colorado
Independent Clinical Reviewer
Mark Reichelderfer, MD
Professor of Medicine
Section of Gastroenterology and Hepatology
University of Wisconsin
Madison, Wisconsin
Target Audience
This activity is designed for managed markets physicians and pharmacists.
Learning Objectives
After completing this activity, participants should be able to:

• Recognize the physical and psychological burden of ulcerative colitis in the United States
• Differentiate ulcerative colitis from similar inflammatory bowel diseases
• Describe the impact of adverse effects on ulcerative colitis treatment decisions
• Apply clinical and economic data to assess the role of different pharmacotherapeutic regimens in the management of ulcerative colitis from a managed markets perspective

Activity Overview
The teleconference lecture will be presented on 4 dates in July and August by William J. Sandborn, MD, with a live question-and-answer session following each presentation.
To participate, dial toll-free 800-803-7101 approximately 5 minutes before the scheduled time of the teleconference. Upon calling in, provide the activity code, Ulcerative Colitis.
An activity booklet, including the lecture slides, post-test, and evaluation form, will be forwarded to each participant prior to the start of the teleconference series. To be eligible for documentation of credit, participants must attend a full teleconference event, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit. Those who mail or fax back their successfully completed post-test and evaluation form will receive documentation of credit by mail within 6 weeks.
There is no fee associated with this activity.
CME Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Cincinnati and Princeton CME. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
The University of Cincinnati designates this educational activity for a maximum of 1 AMA PRA Category 1 Creditâ„¢. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CPE Accreditation
 Princeton CME is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education (ACPE Provider #452) and complies with the Criteria for Quality and Interpretive Guidelines. This activity is approved for 1 hour credit (0.1 CEU) of continuing pharmacy education (ACPE #452-999-07-009-L01).
Grant Support
Supported by an educational grant from Shire Pharmaceuticals Inc.
Representatives of the granting organization may not register on behalf of participants.   
REGISTER NOW